Cosmetic products sold in the United States, including vitamin C and tranexamic acid serums, do not require pre-market FDA approval. The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act), which holds manufacturers and brand owners responsible for product safety but does not require them to register formulas or obtain approval before going to market. This is fundamentally different from drugs and supplements.
However, "no pre-market approval" does not mean "no regulatory obligations." Several requirements apply. First, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) introduced new mandatory requirements for cosmetic brands selling in the US: facility registration with the FDA (required for manufacturers and processors), product listing with the FDA for each cosmetic product, and adverse event recordkeeping. These requirements took effect in 2024 and apply to most commercial cosmetic brands.
Second, your label must comply with FDA cosmetic labeling regulations under 21 CFR Part 701. This includes a proper INCI ingredient declaration (ingredients listed in descending order of predominance), net quantity of contents, identity of product, and name and address of the responsible party. Failure to comply with labeling rules can result in the product being considered misbranded.
Third, and critically for TXA and vitamin C serums, your label claims must not cross into drug claim territory. A claim like "visibly evens skin tone" is a permissible cosmetic claim. A claim like "treats melasma" or "reduces hyperpigmentation caused by sun damage" implies a physiological effect that the FDA may interpret as a drug claim, which would require a full New Drug Application (NDA). This distinction is where many indie founders inadvertently create regulatory exposure. Have a regulatory consultant review your label copy before printing.
For EU sales, the regulatory pathway is more involved — a Cosmetic Product Safety Report (CPSR), EU Responsible Person designation, and CPNP portal notification are all required. For UK sales post-Brexit, a separate UK Responsible Person and SCPN notification are needed.
Your contract manufacturer's regulatory team should assist with INCI declaration and flag any ingredient or labeling concerns before production. If they don't offer this support, consider it a gap in their service offering.
Ingredients in this answer: Tranexamic Acid
Read the full guide on Private Label Tranexamic Acid Vitamin C Serum Manufacturer →